Binding of anti-HIV drugs to human serum albumin

IUBMB Life

Volumn 56, Issue 10, 2004, Pages 609-614

  Bocedi, Alessio ^a,b   Notaril, Stefania ^a,b   Narciso, Pasquale ^a   Bolli, Alessandro ^b   Fasano, Mauro ^c   Ascenzi, Paolo ^a,b  

^a NATIONAL INSTITUTE FOR INFECTIOUS DISEASES L SPALLANZANI   (Italy)

^b ROMA TRE UNIVERSITY   (Italy)

^c UNIVERSITY OF INSUBRIA   (Italy)

Author keywords

Anti HIV drugs; Drug affinity; Drug binding; Human serum albumin; Intrinsic tryptophan fluorescence quenching; Non nucleoside reverse transcriptase inhibitors; Nucleoside reverse transcriptase inhibitors; Protease inhibitors

Indexed keywords

ABACAVIR; ATAZANAVIR; DIDANOSINE; EFAVIRENZ; EMTRICITABINE; HUMAN SERUM ALBUMIN; IBUPROFEN; LAMIVUDINE; NELFINAVIR; NEVIRAPINE; PLASMA PROTEIN; PROTEINASE; RITONAVIR; RNA DIRECTED DNA POLYMERASE INHIBITOR; SAQUINAVIR; STAVUDINE; TRYPTOPHAN; ZALCITABINE; ZIDOVUDINE;

ARTICLE; DRUG ACTIVITY; DRUG BINDING; FLUORESCENCE; LIGAND BINDING;

ANTI-HIV AGENTS; ANTIVIRAL AGENTS; HIV PROTEASE; HIV PROTEASE INHIBITORS; HUMANS; IBUPROFEN; KINETICS; LIGANDS; MICROSCOPY, FLUORESCENCE; MODELS, MOLECULAR; PROTEIN STRUCTURE, SECONDARY; PROTEIN STRUCTURE, TERTIARY; SERUM ALBUMIN; SPECTROMETRY, FLUORESCENCE; TRYPTOPHAN;

EID: 15244350529     PISSN: 15216543     EISSN: None     Source Type: Journal    
DOI: 10.1080/15216540400016286     Document Type: Article

References (37)

1. Peters, T., Jr., ed. (1996) All about Albumin: Biochemistry, Genetics and Medical Applications. Academic Press, San Diego and London.
2. Curry, S., Mandelokov, H., Brick, P., and Franks, N. (1998) Crystal structure of human serum albumin complexed with fatty acid reveals an asymmetric distribution of binding sites. Nat. Struct. Biol. 5, 827-835.
3. Dockal, M., Carter, D. C., and Rüker, F. (1999) The three recombinant domains of human serum albumin. Structural characterization and ligand binding properties. J. Biol. Chem. 274, 29303-29310.
4. Sugio, S., Kashima, A., Mochizuki, S., Noda, M., and Kobayashi, K. (1999) Crystal structure of human serum albumin at 2.5 Å resolution. Protein Eng. 12, 439-446.
5. Bhattacharya, A. A., Curry, S., and Franks, N. P. (2000) Binding of the general anesthetics propofol and halothane to human serum albumin. High resolution crystal structures. J. Biol. Chem. 275, 38731-38738.
6. Bhattacharya, A. A., Grüne, T., and Curry, S. (2000) Crystallographic analysis reveals common modes of binding of medium and long-chain fatty acids to human serum albumin. J. Mol. Biol. 303, 721-732.
7. Fasano, M., Baroni, S., Vannini, A., Ascenzi, P., and Aime, S. (2001) Relaxometric characterization of human hemalbumin. J. Biol. Inorg. Chem. 6, 650-658.
8. Mattu, M., Vannini, A., Coletta, M., Fasano, M., and Ascenzi, P. (2001) Effect of bezafibrate and clofibrate on the heme-iron geometry of ferrous nitrosylated heme-human serum albumin: an EPR study. J. Inorg. Biochem. 84, 293-296.
9. Zunszain, P. A., Ghuman, J., Komatsu, T., Tsuchida, E., and Curry, S. (2003) Crystal structural analysis of human serum albumin complexed with hemin and fatty acid. BMC Struct. Biol. 3, 6.
10. Hamilton, J. A. (2004) Fatty acid interactions with proteins: what X-ray crystal and NMR solution structures tell us. Prog. Lipid. Res. 43, 177-199.
11. Sakurai, Y., Ma, S. F., Watanabe, H., Yamaotsu, N., Hirono, S., Kurono, Y., Kragh-Hansen, U., and Otagiri, M. (2004) Esterase-like activity of serum albumin: characterization of its structural chemistry using p-nitrophenyl esters as substrates. Pharm. Res. 21, 285-292.
12. Petitpas, I., Petersen, C. E., Ha, C. E., Bhattacharya, A. A., Zunszain, P. A., Ghuman, J., Bhagavan, N. V., and Curry, S. (2003) Structural basis of albumin-thyroxine interactions and familial dysalbuminemic hyperthyroxinemia. Proc. Natl. Acad. Sci. USA 100, 6440-6445.
13. He, X., and Carter, D. C. (1992) Atomic structure and chemistry of human serum albumin. Nature 358, 209-215.
14. Carter, D. C., Ho, J. X., and Ruker, F. (1999) Oxygen-transporting albumin-based blood replacement composition and blood volume expander. U.S. Pat. No. 5,948,609.
15. Dockal, M., Chang, M., Carter, D. C., and Rüker, F. (2000) Five recombinant fragments of human serum albumin. Tools for the characterization of the warfarin binding site. Protein Sci. 9, 1455-1465.
16. Sudlow, G., Birkett, D. J., and Wade, D. N. (1975) The characterization of two specific drug binding sites on human serum albumin. Mol. Pharmacol. 11, 824-832.
17. Whitlam, J. B., Crooks, M. J., Brown, K. F., and Pedersen, P. V. (1979) Binding of nonsteroidal anti-inflammatory agents to proteins. I. Ibuprofen-serum albumin interaction. Biochem. Pharmacol. 28, 675-678.
18. Diana, F. J., Veronich, K., and Kapoor, A. L. (1989) Binding of nonsteroidal anti-inflammatory agents and their effect on binding of racemic warfarin and its enantiomers to human serum albumin. J. Pharm. Sci. 78, 195-199.
19. Pinkerton, T. C., and Koeplinger, K. A. (1990) Determination of warfarin-human serum albumin protein binding parameters by an improved Hummel-Dreyer high-performance liquid chromatographic method using internal surface reversed-phase columns. Anal. Biochem. 62, 2114-2122.
20. Loun, B., and Hage, D. S. (1994) Chiral separation mechanisms in protein-based HPLC columns: 1. thermodynamic studies of (R)- and (S)-warfarin binding to immobilized human serum albumin. Anal. Chem. 66, 3814-3822.
21. James, E., and Reynolds, F., eds (1996) Martindale, J., The Extra Pharmacopoeia, 31st Edition. The Pharmaceutical Press, London.
22. Petitpas, I., Bhattacharya, A. A., Twine, S., East, M., and Curry, S. (2001) Crystal structure analysis of warfarin binding to human serum albumin: anatomy of drug site I. J. Biol. Chem. 276, 22804-22809.
23. Herman, H. M., Westbrook, J., Feng, Z., Gilliland, G., Bhat, T. N., Weissig, H., Shindyalov, I. N., and Bourne, P. E. (2000) The Protein Data Bank. Nucl. Acids Res. 28, 235-242.
24. Sułkowska, A., Bojko, B., Ro'wnicka, J., and Sułkowski, W. (2004) Competition of drugs to serum albumin in combination therapy. Biopolymers 74, 256-262.
25. Petersen, C. E., Ha, C. E., Jameson, D. M., and Bhagavan, N. V. (1996) Mutations in a specific human serum albumin thyroxine binding site define the structural basis of familial dysalbuminemic hyperthyroxinemia. J. Biol. Chem. 271, 19110-19117.
26. Epps, D. E., Raub, T. J., Caiolfa, V., Chiari, A., and Zamai, M. (1999) Determination of the affinity of drugs toward serum albumin by measurement of the quenching of the intrinsic tryptophan fluorescence of the protein. J. Pharm. Pharmacol. 51, 41-48.
27. Mahammed, A., Gray, H. B., Weaver, J. J., Sorasaenee, K., and Gross, Z. (2004) Amphiphilic coroles bind tightly to human serum albumin. Bioconjug. Chem. 15, 738-746.
28. Wyman, J. Jr. (1964) Linked functions and reciprocal effects in hemoglobin: a second look. Adv. Protein. Chem. 19, 223-286.
29. Ascenzi, P., and Amiconi, G. (1987) Logarithmic plots in enzymology. Representation of the Michaelis-Menten equation. Biochem. Educ. 15, 83-84.
30. Schön, A., del Mar Ingaramo, M., and Freire, E. (2003) The binding of HIV-1 protease inhibitors to human serum proteins. Biophys. Chem. 105, 221-230.
31. Gaudreau, S., Neaut, J. F., and Tajmir-Riahi, H. A. (2002) Interaction of AZT with human serum albumin studied by capillary electrophoresis, FTIR and CD spectroscopic methods. J. Biomol. Struct. Dyn. 19, 1007-1014.
32. Kragh-Hansen, U. (1981) Molecular aspects of ligand binding to serum albumin. Pharmacol. Rev. 33, 17-53.
33. Baroni, S., Mattu, M., Vannini, A., Cipollone, R., Aime, S., Ascenzi, P., and Fasano, M. (2001) Effect of ibuprofen and warfarin on the allosteric properties of haem-human serum albumin. A spectroscopic study. Eur. J. Biochem. 268, 6214-6220.
34. Molla, A., Vasavanonda, S., Kumar, G., Sham, H. L., Johnson, M., Grabowski, B., Denissen, J. F., Kohlbrenner, W., Plattner, J. J., Leonard, J. M., et al. (1998) Human serum attenuates the activity of protease inhibitors toward wild-type and mutant human immunodeficiency virus. Virology 250, 255-262.
35. Anderson, S. R., and Antonini, E. (1968) The binding of carbon monoxide by human hemoglobin. Proof of validity of the spectrophotometric method and direct determination of the equilibrium. J. Biol. Chem. 243, 2918-2920.
36. 2S solubility via the reaction with ferric hemoglobin 1 from the bivalve mollusc Lucina pectinata. Biochim. Biophys. Acta 1523, 206-208.
37. Bertucci, C., and Domenici, E. (2002) Reversible and covalent binding of drugs to human serum albumin: methodological approaches and physiological relevance. Curr. Med. Chem. 9, 1463-1481.